Market revenue in 2023 | USD 13.6 million |
Market revenue in 2030 | USD 17.4 million |
Growth rate | 3.6% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.53% in 2023. Horizon Databook has segmented the Saudi Arabia in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia’s IVD quality control market is expected to show poised growth over the forecast period. Increasing adoption rate of technologically advanced diagnostic devices is anticipated to drive the calibration and internal & external quality assurance needs for laboratories to maintain the safety and accuracy of IVD tests.
Moreover, an increase in consumer demand due to the growing prevalence of chronic illnesses, a higher need for localized testing, a growing geriatric population, and technological advancements are expected to aid market growth over the forecast period.
According to GLOBOCAN, 27,885 new cancer cases with 13,069 deaths were reported in Saudi Arabia. Among new cancer patients, 14,253 cases were reported in males, while 13,632 cases were in females.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account